Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €52.75 EUR
Change Today +0.14 / 0.27%
Volume 170.0
MRK On Other Exchanges
New York
EN Paris
Sao Paulo
As of 5:16 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kenneth C. Frazier

Chairman, Chief Executive Officer and President, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 41 board members in 3 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Kenneth C. Frazier, also known as Ken, has been the President of Merck & Co. Inc. since May 1, 2010 and has also been its Chief Executive Officer since January 1, 2011. Mr. Frazier served as the President of Global Human Health at Merck & Co. Inc. since August 1, 2007. Mr. Frazier served as an Executive Vice President of Merck & Co. Inc. since November 2006. He served as Senior Vice President of Merck & Co. Inc. from December 1999 to November 2006 and General Counsel ...

Read Full Background

Corporate Headquarters*

2000 Galloping Hill Road
Kenilworth, New Jersey 07033

United States

Phone: 908-740-4000
Fax: --

Board Members Memberships*

Former Manager, Senior Vice President of Merck & Co Inc and General Counsel of Merck & Co Inc
Director, Chairman of Board Affairs Committee and Member of Public Issues & Contributions Committee
Chairman, Chief Executive Officer and President


BA 1975
Pennsylvania State University
JD 1978
Harvard Law School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,500,000

Stock Options*

Restricted Stock Awards$5,105,338
All Other Compensation$232,825
Exercisable Options1,755,331
Exercisable Options Value$23,498,204
Unexercisable Options1,293,821
Unexercisable Options Value$10,765,788
Total Value of Options$34,263,991
Total Number of Options3,049,152

Total Compensation*

Total Annual Cash Compensation$3,352,825
Total Short Term Compensation$1,500,000
Other Long Term Compensation$5,338,163
Total Calculated Compensation$13,375,935
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:FP €52.75 EUR +0.14


John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Strategy Committee and Chairman of Appointments & Governance Committee
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at